Atlas Trials

Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer

Clinical trial NCT00749892 · COMPLETED

Trial details

NCT number
NCT00749892
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Bladder Urothelial CarcinomaRecurrent Renal Pelvis Urothelial CarcinomaRecurrent Ureter Urothelial CarcinomaRecurrent Urethral Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0a Renal Pelvis Cancer AJCC v8Stage 0a Ureter Cancer AJCC v8Stage 0a Urethral Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8Stage 0is Renal Pelvis Cancer AJCC v8Stage 0is Ureter Cancer AJCC v8Stage 0is Urethral Cancer AJCC v8
Start date
2008-06-10
Primary completion
2019-06-30
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.